141 filings
Page 3 of 8
8-K
thxnmzhifmqc8wygc
6 Dec 22
Departure of Directors or Certain Officers
4:37pm
8-K
xa9lmszwnwx3cghts3jm
10 Nov 22
Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update
4:01pm
8-K
q0hid x5e5sf
17 Oct 22
Regulation FD Disclosure
6:07am
8-K
u6v068cjcbjchs
10 Aug 22
Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update
4:38pm
8-K
ox4focnt
8 Jul 22
Submission of Matters to a Vote of Security Holders
4:00pm
DEFA14A
to0pke1fafdm0k9
2 May 22
Additional proxy soliciting materials
5:17pm
PRE 14A
17pxkajxlq
21 Apr 22
Preliminary proxy
9:00pm
8-K
rbyvh
24 Mar 22
Index to Consolidated Financial Statements
7:42am
S-8
4vnmlfqes57lkfc
24 Mar 22
Registration of securities for employees
7:36am
8-K
yv7zvbmexad7c 0cx9ha
16 Feb 22
Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer
7:37am
EFFECT
g1ztvxo7
3 Feb 22
Notice of effectiveness
12:15am
CORRESP
okysyq8uxigudjg9d
31 Jan 22
Correspondence with SEC
12:00am
UPLOAD
50hgpf
19 Nov 21
Letter from SEC
12:00am
8-K
b0iqf3ru jz6ub
12 Nov 21
Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update
7:38am